Article info
PDFResearch
End-of-life prescribing of aspirin in patients with breast or colorectal cancer
- Correspondence to Ms. Amelia Smith, Department of Pharmacology and Therapeutics, Trinity College, University of Dublin, Trinity Centre for Health Sciences, St. James' Hospital, Dublin 8, Ireland D08 W9RT; smitha25{at}tcd.ie
Citation
End-of-life prescribing of aspirin in patients with breast or colorectal cancer
Publication history
- Received April 25, 2017
- Revision received July 24, 2017
- Accepted July 26, 2017
- First published August 24, 2017.
Online issue publication
February 19, 2019
Article Versions
- Previous version (19 February 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.